China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Beijing-Pyongyang passenger rail service to resume Thursday
- Shanghai and Jiangsu integration boosts sports-tourism development
- China Eastern Airlines restores direct flights between Shanghai and Stockholm
- RedNote targets AI-run accounts with new governance rules
- China's draft law on ethnic unity aims to serve as global model, political adviser
- Spring blossoms complement the Honghe Hani Rice Terraces in Yunnan
